Reproductive & Genetic Health
Elevating the standard for prenatal screening
Noninvasive Prenatal Testing
Noninvasive prenatal testing (NIPT) analyzes cell-free DNA from a maternal blood sample to screen for common chromosomal conditions as early as 10 weeks gestation.
Illumina NIPT uses whole-genome next-generation sequencing (NGS) technology. The test analyzes cfDNA fragments across the whole genome, which has advantages over other NIPT methodologies, including targeted sequencing and array-based tests.
Popular reproductive health resources
NIPT vs traditional aneuploidy screening methods
Although both are aneuploidy screens, maternal serum screening and NIPT blood tests have different accuracy rates, time to results, and implementation.
NIPT technology types
NIPT typically utilizes whole-genome sequencing using next-generation sequencing (NGS) or targeted methods. When evaluating the best NIPT approach, you’ll want to consider data generation and analysis, lab workflow, and resulting clinical implications.
Additional resources
VeriSeq NIPT Solution V2
A simple, yet comprehensive in-lab automated NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.
VeriSeq: Expect the extraordinary in prenatal screening
This video highlights the simplicity, scalability, and accuracy of VeriSeq NIPT Solution v2 for in-lab IVD NIPT screening.